Transitional cell carcinoma of the renal pelvis and ureter.
- Author:
Ho Seung YANG
1
;
Soo Bang RYU
Author Information
1. Department of Urology, Chonnam University Medical School, Kwanju, Korea.
- Publication Type:Original Article
- Keywords:
transitional cell carcinoma
- MeSH:
Carcinoma, Transitional Cell*;
Doxorubicin;
Drug Therapy;
Female;
Follow-Up Studies;
Hematuria;
Humans;
Kidney Pelvis*;
Male;
Survival Rate;
Ureter*;
Urinary Bladder Neoplasms;
Vinblastine
- From:Korean Journal of Urology
1992;33(4):626-631
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Thirty-two patients with transitional cell carcinoma of the renal pelvis and ureter were analyzed to determine whether there was any correlation between tumor characteristics and patient survival. The patients consisted of 26 male and 6 female. Patient age ranged from 12 to 80 years with a mean of 53.6 years. Of these patients. 28 were followed for 1 to 10 years. The most common presenting symptom was hematuria (87.5% ). Excretory urogram demonstrated NVK (nonvisualization or the kidney) in 16 patients and filling defect in 10. Pathologically. 31% of the patients were stage T1. 46% stage T2, 12% stage T3 and l6% stage T4. Histologically, 16% of the patients had grade I . 47% grade II and 37% grade III disease. Recently 6 patients, of whom 5 presented with stage T2 and 1 with stage T4. were treated postoperatively with adjuvant M-VAC (methotrexate, vinblastine. adriamycin and cisplantin) chemotherapy. H these 6 patients, 3 had subsequently recurrent tumor and their mean survival was 15 months. The 2 years survival rates of 28 patients follow-up were 90.0, 45.5, 33.3 and 0% for stage T1, T2, T3 and T4 disease, respectively, and 100, 66.7 and 10% for grade I to III disease, respectively. Overall 2 years and 5 years survival rates were 53.6% and 23.1% respectively. It is concluded from this study that age, sex. NVK on excretory urogram. synchronous or metachronous bladder tumors seem to have no influence on patient survival while patient survival correlates with stage and grade of tumor.
